TITLE

Short-course eflornithine in Gambian trypanosomiasis: a multicentre randomized controlled trial

AUTHOR(S)
Pepin, Jacques; Khonde, Nzambi
PUB. DATE
November 2000
SOURCE
Bulletin of the World Health Organization;2000, Vol. 78 Issue 11, p1284
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Compares the effectiveness of 7 days of intravenous eflornithine with the standard 14-day regimen in the treatment of late-stage Trypanosoma brucei gambiense trypanosomiasis. Use of a randomized controlled trial; Death of some patients during treatment; Difference in response to treatment according to country; Probability of cure of the different regimens.
ACCESSION #
4002466

 

Related Articles

  • Novel Markers for Treatment Outcome in Late-Stage Trypanosoma brucei gambiense Trypanosomiasis. Lejon, Veerle; Roger, Isabelle; Ngoyi, Dieudonné Mumba; Menten, Joris; Robays, Jo; N'Siesi, Francois X.; Bisser, Sylvie; Boelaert, Marleen; Büscher, Philippe // Clinical Infectious Diseases;7/1/2008, Vol. 47 Issue 1, p15 

    Background. To date, no biological marker for treatment outcome in human African trypanosomiasis (HAT) has been described. The accuracy of biological markers for prediction of treatment outcome of HAT caused by Trypanosoma brucei gambiense was assessed. Methods. Cerebrospinal fluid (CSF) white...

  • Mechanism of resistance of African trypanosomes to cytotoxic human HDL. Hager, Kristin M.; Hajduk, Stephen L. // Nature;2/27/1997, Vol. 385 Issue 6619, p823 

    Reports that resistant trypanosomes fail to endocytose trypanosome lytic factor (TLF). The continued binding of TLF through cell-surface receptors; The suggestion for a possible mechanism of resistance of human sleeping sickness trypanosomes to human serum; The implications for Trypanosoma...

  • Mechanism of resistance of African trypanosomes to cytotoxic human HDL. Hager, Kristin M.; Hajduk, Stephen L. // Nature;2/27/1997, Vol. 385 Issue 6619, p823 

    Reports that resistant trypanosomes fail to endocytose trypanosome lytic factor (TLF). The continued binding of TLF through cell-surface receptors; The suggestion for a possible mechanism of resistance of human sleeping sickness trypanosomes to human serum; The implications for Trypanosoma...

  • Structural analysis of adenylate cyclases from Trypanosoma brucei in their monomeric state. Bieger, Boris; Essen, Lars-Oliver // EMBO Journal;9/15/2001, Vol. 20 Issue 18, p5302 

    Presents a correction to the article "Structural Analysis of Adenylate Cyclases From Trypanosoma Brucei in Their Monomeric State," by Boris Bieger and Lars-Oliver Essen that was previously published in the EBMO Journal.

  • Gambiense sleeping sickness: re-emerging and soon untreatable? Van Nieuwenhove, Simon // Bulletin of the World Health Organization;2000, Vol. 78 Issue 11, p1283 

    Editorial. Comments on the return of sleeping sickness caused by Trypanosoma brucei gambiense. Deterioration and disruption of control activities; Problems on the implementation of active case detection and successful treatment; Gap between scientific progress and the implementation of...

  • Isolation And Characterization Of Two Distinct Atp-Independent Topoisomerase Ii Activities From The Trypanosomatid Trypanosoma Brucei Brucei. Vittal, Vasanthi R.; Sekher, Anuradha; Carter, Barbara J. // Protein & Peptide Letters;Feb2001, Vol. 8 Issue 1, p1 

    In a rapid purification procedure, two distinct type II topoisomerase activities (decatenation and catenation) have been isolated from the whole cell extracts of Trypanosoma brucei brucei. Both decatenating and catenating activities were detected in the cell extracts, but these two activities...

  • Microbiology: Fighting to stay awake. Miura, Grant // Nature Chemical Biology;Sep2013, Vol. 9 Issue 9, p529 

    The article presents information on the findings of a study on RNAi revealed that TbGSK3short and a TbCLK1 kinase were required for Trypanosoma brucei viability.

  • The role of transferrin-receptor variation in the host range of Trypanosoma brucei. Bitter, W.; Gerrits, H.; Kieft, R.; Borst, P. // Nature;1/29/1998, Vol. 391 Issue 6666, p499 

    Presents research which studied the effects of small differences between transferrin receptors on the binding activity for transferrins from different mammals. Use of the parasite Trypanosoma brucei; How the parasite multiplies and survives; How the parasite takes up transferrin; Different...

  • Apolipoprotein L-I is the trypanosome lytic factor of human serum. Vanhamme, Luc; Paturiaux-Hanocq, Francoise; Poelvoorde, Philippe; Nolan, Derek P.; Lins, Laurence; Van Den Abbeele, Jan; Pays, Annette; Tebabi, Patricia; Van Xong, Huang; Jacquet, Alain; Moguilevsky, Nicole; Dieu, Marc; Kane, John P.; De Baetselier, Patrick; Brasseur, Robert; Pays, Etienne // Nature;3/6/2003, Vol. 422 Issue 6927, p83 

    Human sleeping sickness in east Africa is caused by the parasite Trypanosoma brucei rhodesiense. The basis of this pathology is the resistance of these parasites to lysis by normal human serum (NHS). Resistance to NHS is conferred by a gene that encodes a truncated form of the variant surface...

  • The Cell Biology of Parasitism in Trypanosoma brucei: Insights and Drug Targets from Genomic Approaches? Gull, K. // Current Pharmaceutical Design;Feb2002, Vol. 8 Issue 4, p241 

    The African trypanosome, Trypanosoma brucei exhibits a complex, digenetic life cycle that alternates between the tsetse fly vector and the mammalian host. The life cycle is characterised by a complex series of cell type differentiations and variations in metabolism. In addition the trypanosome...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics